Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-033129
Filing Date
2018-05-24
Accepted
2018-05-24 18:22:39
Documents
2
Period of Report
2018-05-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6987
2 EX-24 DOCUMENT attachment1.htm EX-24 5624
  Complete submission text file 0001209191-18-033129.txt   14091
Mailing Address 2765 SAND HILL ROAD MENLO PARK CA 94025
Business Address
Ahrens Brenton Karl (Reporting) CIK: 0001322927 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38503 | Film No.: 18859082

Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Issuer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations